JUNCTURE WEALTH STRATEGIES, LLC

Position in HALO — Halozyme Therapeutics, Inc.

CIK 1632866 SCOTTSDALE, AZ

Position in HALO

as of Jun 30, 2026 · filed Jul 9, 2026 Compact

Position Value

$928,673

+$238,360 QoQ

Shares Held

11,865

+11.1% QoQ

Ownership

0.010%

of shares outstanding

% of Portfolio

1.33%

of 13F equity value

Holder Rank

#97

of 287 holders

Holding Since

Mar 2024

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

JUNCTURE WEALTH STRATEGIES, LLC holds $4,939,567 across 9 Biotechnology names. HALO ranks #1 (18.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	HALO	Halozyme Therapeutics, Inc. This page	11,865	$928,673
2	PTCT	Ptc Therapeutics, Inc.	10,577	$862,765
3	AUPH	Aurinia Pharmaceuticals Inc.	34,232	$580,917
4	CPRX	Catalyst Pharmaceuticals, Inc.	18,408	$578,563
5	MIRM	Mirum Pharmaceuticals, Inc.	4,815	$563,692
6	INCY	Incyte Corp	4,956	$561,812
7	VCEL	Vericel Corp	8,283	$368,510
8	TBPH	Theravance Biopharma, Inc.	17,234	$292,978

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$928,673	11,865	+11.1%	Shares	Sole	2026-07-09
2026-03-31	$690,313	10,681	-2.7%	Shares	Sole	2026-04-15
2025-12-31	$738,617	10,975	-1.3%	Shares	Sole	2026-01-27
2025-09-30	$815,100	11,114	+5.5%	Shares	Sole	2025-10-14
2025-06-30	$547,978	10,534	-14.9%	Shares	Sole	2025-07-08
2025-03-31	$790,286	12,385	+3.4%	Shares	Sole	2025-04-10
2024-12-31	$572,668	11,978	-0.7%	Shares	Sole	2025-01-21
2024-09-30	$690,199	12,058	+3.6%	Shares	Sole	2024-10-09
2024-06-30	$609,627	11,643	+56.1%	Shares	Sole	2024-07-11
2024-03-31	$303,432	7,459	—	Shares	Sole	2024-04-05
No filing history on record for this holder in this stock.